Table 2.
Compound | UMP (at admission) | Psychosis (<2 weeks in hospital) | Follow-up (>8 weeks treatment) | Control | Datapoints excluded or missing |
---|---|---|---|---|---|
IL6 (pg/ml) | 3.09 ± 6.83 | 0.38 ± 1.12 | 0.20 ± 0.21 | 0.16 ± 0.26 | N = 11 |
IL8 (ng/ml) | 0.98 ± 4.17 | 1.30 ± 4.61 | 0.20 ± 0.77 | 0.03 ± 0.08 | N = 4 |
IL1RA (ng/ml) | 0.33 ± 0.16 | 0.28 ± 0.15 | 0.25 ± 0.07 | 0.22 ± 0.07 | N = 16 |
IL1B (pg/ml) | 0.07 ± 0.29 | 0.03 ± 0.08 | 0.02 ± 0.08 | 0.27 ± 1.86 | N = 25 |
TNFα (pg/ml) | 8.01 ± 5.55 | 6.23 ± 5.51 | 6.35 ± 6.41 | 5.44 ± 4.02 | N = 41 |
CRP (μg/ml) | 4.03 ± 6.22 | 2.18 ± 3.10 | 2.20 ± 1.99 | 1.00 ± 1.22 | N = 4 |
CCL2 (pg/ml) | 99.12 ± 36.96 | 82.99 ± 24.80 | 88.85 ± 36.06 | 75.17 ± 27.46 | N = 3 |
Trp (μg/ml) | 10.68 ± 2.66 | 10.57 ± 2.19 | 10.21 ± 1.93 | 10.88 ± 1.76 | N = 0 |
Kyn (ng/ml) | 172.30 ± 36.58 | 165.64 ± 40.45 | 179.38 ± 43.41 | 185.16 ± 47.09 | N = 0 |
KA (ng/ml) | 5.22 ± 1.62 | 5.05 ± 2.03 | 5.35 ± 1.99 | 6.83 ± 2.66 | N = 0 |
QA (ng/ml) | 72.39 ± 24.79 | 78.55 ± 30.59 | 91.43 ± 38.88 | 88.39 ± 25.17 | N = 0 |
3-HK (nmol/l) | 27.95 ± 8.98 | 28.77 ± 14.55 | 32.04 ± 16.09 | 35.69 ± 15.53 | N = 16 |
Nitrite | 26.16 ± 15.86 | 59.86 ± 34.151 | 63.64 ± 34.25 | 39.47 ± 30.16 | N = 6 |
Neopterin | 5.80 ± 2.07 | 5.44 ± 2.31 | 6.50 ± 5.15 | 5.56 ± 2.74 | N = 6 |
Data are expressed as mean values ± SD. Phe and Tyr are not represented due to significant batch effects.